Keyphrases
Liver Resection
100%
Colorectal Liver Metastases
100%
Clinical High Risk
100%
Thermal Ablation
100%
High Surgical Risk
100%
Resective Surgery
100%
Netherlands
33%
Disease-free Survival
33%
Ablation
33%
Internal pilot Study
33%
Surgery Patients
16%
Length of Hospital Stay
16%
Quality of Life
16%
Curative Treatment
16%
Computed Tomography
16%
Europe
16%
Surgeons
16%
Surgical Resection
16%
Overall Survival
16%
Survival Data
16%
Statistical Analysis
16%
Record Linkage
16%
Cost-effectiveness
16%
Recurrence Rate
16%
Patient Preference
16%
Blinded Study
16%
Gallbladder
16%
Treatment Failure
16%
Liver
16%
5-year Survival
16%
Clinical Efficacy
16%
Comorbidity Burden
16%
Multidisciplinary Team
16%
Randomized Controlled Non-inferiority Trial
16%
Group Randomized
16%
Local Policy
16%
Tumor Burden
16%
Clinical Costs
16%
Surgeon Preference
16%
Research nurse
16%
National Institute for Health Research
16%
Additional Therapy
16%
Recurrence Site
16%
Initial Feasibility
16%
Hepatopancreatobiliary
16%
Random Element
16%
Post-randomization
16%
Clinical Equipoise
16%
Unconscious Bias
16%
INIS
liver
100%
patients
100%
surgery
100%
risks
100%
comparative evaluations
100%
metastases
100%
ablation
100%
lava
100%
diseases
18%
cost
18%
netherlands
18%
interventions
18%
data
9%
tumors
9%
therapy
9%
policy
9%
optimization
9%
length
9%
hospitals
9%
reviews
9%
quality of life
9%
computed tomography
9%
pancreas
9%
design
9%
failures
9%
europe
9%
randomness
9%
guidelines
9%
adults
9%
minimization
9%
feasibility studies
9%
gallbladder
9%
Medicine and Dentistry
Randomized Controlled Trial
100%
Surgical Risk
100%
Hepatectomy
100%
Colorectal Liver Metastasis
100%
Surgeon
33%
Disease Free Survival
33%
Computer Assisted Tomography
16%
Neoplasm
16%
Health Care Cost
16%
Quality of Life
16%
Cost-Effectiveness Analysis
16%
Overall Survival
16%
Recurrent Disease
16%
Recurrence Risk
16%
Gene Linkage
16%
Clinician
16%
Cardiovascular System
16%
Nurse
16%
Arm
16%
Patient Preference
16%
Noninferiority Trial
16%
Clinical Equipoise
16%
Comorbidity
16%